Moderna plans to announce the development of a vaccine candidate that will protect against Covid-19 and the flu, to be known as mRNA-1073. The company will also announce a pediatric vaccine called mRNA-1365, which combines its experimental respiratory syncytial virus vaccine with its experimental human metapneumovirus vaccine.
The news came less than an hour before the company begins an investor event intended to discuss the company’s clinical development pipeline. Top Moderna (ticker: MRNA) executives, including CEO Stéphane Bancel, newly appointed chief medical officer Dr. Paul Burton, and the company’s president, Dr. Stephen Hoge, were due to appear.
Total vaccine doses per 100 people
“There remains a shocking imbalance in the global distribution of vaccines,” WHO Director General Tedros Adhanom Ghebreyesus told a news conference.
Source: BBC News